Share Name Share Symbol Market Type Share ISIN Share Description
Ekf Diagnostics Holdings Plc LSE:EKF London Ordinary Share GB0031509804 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.25 0.56% 44.80 43.40 44.90 44.80 44.70 44.70 155,267 09:18:26
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Health Care Equipment & Services 81.8 21.4 3.5 12.9 204

Ekf Diagnostics Share Discussion Threads

Showing 3576 to 3600 of 4525 messages
Chat Pages: Latest  145  144  143  142  141  140  139  138  137  136  135  134  Older
Re Barclays, the customer service staff were charming but Barclays muddled and indecisive, I was informing the technical support team of where to look via chat yesterday morning. Their apparent solution was this letter confirming holding and entitlement but mine arrived at 17:28 and the password to open the email not until after 17:00. I placed no reliance on this and required detailed interrogation to confirm my identity. I placed reliance on the statements of the EKF directors at the trading announcements where he said if anyone had an issue with buying, get in touch and I did, via Walbrook a pragmatic solution that fully documented entitlement and smoothed the process. Fingers crossed now.
They were not the first in the field but in the end the process at HL was simplicity itself. Job done! I can understand their need to put it through the legal department having read the restrictions myself. They are in effect responsible for certifying that all their clients are 'clean' and have particularly to watch the US dimension.

I had given up hope of an application until I read their email. Given the short notice (and I was out until after the market had closed) it could have been difficult to free up the necessary funds to meet a 7am Monday deadline. Fortunately, spare funds had arrived fortuitously on Wednesday, available via debit card and there was leeway in the ISA subscription. In overall terms it's little more than a dabble - but oaks and acorns and all that.

I would encourage as many applicants as possible who have had problems applying for Trellus shares to give specific feedback directly to EKF.The company has a very good track record of engaging constructively with PIs and I am sure that it will want to know what problems have occurred and then look to effect improvements for the next offering.

Few of the platforms have performed well, but I also think that EKF needs to look at the guidance and procedures that its advisors put in place. With the honourable exception of Interactive Investor, all of the brokers I know were caught on the back foot.

Having a nightmare with Barclays (both the bank and Smart Investor/corporate actions!), the payment from 'cleared funds' has been paused due to their system flagging it up as potential fraud (the bank processed it manually with all security passed etc) and it won't be released/completed until it has been reviewed by their fraud department. Plus, the wrong documents were emailed to me regarding proof of EKF share ownership, which they have acknowledged over three hours ago, but with no replacements yet received.

It has taken me many hours to get even this far, and I still can't complete the transaction!

Just applied through HL, it was straightforward. Not sure when cash will be deducted.

Thanks to all for the advanced warning


Credit ultimately due to Homebrewruss on the Renalytix thread, but I also note that Trellus Health are presenting here too -

Becker's Healthcare

All eyes are on the life sciences sector as digital transformation and innovation booms. Biopharma and medtech companies reacted quickly during the pandemic to accelerate clinical trials and drug development focused on COVID-19 while also advancing important gene therapies and precision medicine initiatives. These companies also made strides in data management and are poised to create extreme value for healthcare over the next few years.

On May 21st, life science experts will come together for a robust 90-minute program to debate the biggest issues and exciting technologies in the industry today. Join us for this unique, focused event and gain an edge on the competition.



Vlado Bosanac, Chairman and Chief Executive Officer, Advanced Human Imaging (AHI)

Rick Anderson, president and general manager, North America, DarioHealth

Monique Fayad, CEO, Trellus Health


Better late than never,but not impressed with HL. They are always slow on the uptake....not good enough for the biggest UK broker!
I am also a client of HL and I see they now have the option to subscribe for the Trellus Restricted Offer (as my millie mentions above). Well done to all those who pressed HL on this issue and well done to HL for reacting (even if it took them a bit longer than we might have liked).
jane deer
Thanks for responding, appreciate the debate.

Thanks for correcting me as it was my understanding and I can agree with some of what you said. Although I just re-read the March end of year and it said 2020 core revenue was -14% compared to 2019. Their diabetes’s diagnostic products were down significantly more. Seems primestore and all the infrastructure and lab work around that is what carried the business in 2020 hence appearing to be a COVID play (I also guess COVID play means differently to different people) BUT that doesn’t mean they cannot grow out of that, their business is likely to be more recognisable in the market because of the pandemic.

I believe in the business but did initially invest on the antibody tests speculative demand. Ultimately I’m here to make money so the share price needs to move upwards.

I have just received this message from HL

Thank you for your message and my apologies for the delay in responding.

Our compliance team needed to review the Trellus Health plc Restricted Offer to confirm whether we are able to offer it to our clients. The have now confirmed our clients can participate in the offer and we will send a message this afternoon on how to take part.

There is a very short turnaround time on this action, the deadline to submit your instruction will be 7am Monday 24 May 2021.

TO briefly answer Sensnsibull's points above: At the AGM they did not state that were not a Covid play, they stated that they see demand for their 'white-label' testing kits lasting for a long time to come and indeed are investing to meet demand."Our largest contract is for a minimum of two years. In addition, we continue to win new clients who may add to our current production." The big customer cannot be named because of the PR dept only, but they felt that will soon change. And finally I will correct you because you are wrong : the core business is flying, that was made crystal clear at the AGM. If you read the AGM statement .... "the Board is now confident that trading for the full year will be comfortably ahead of already upgraded management expectations." If you find another company with this amount of potential please to put your money into please let us know.
Mine are in an ISA share dealing account with Interactive Investor and it was a simple process of populating a box with my preference of amount to invest
For anyone who happens to hold their qualifying shares in a CREST sponsored account, you have to apply direct to the company. It is a painful and long winded process.
I hold my shares in a SIPP with Interactive Investor. They now have a very simple application notice in the corporate actions folder under the portfolio tab.
Hi cambridgedon. In the end I decided not to bother, as (1) I had other stocks to buy, (2) I already had a holding in Trellus via the dividend in specie, (3) it's not the type of stock I usually like to have a large stake in, with no revenues as at Dec'20, and (4) I couldn't be bothered with the faff of the paperwork and rushed timetable. Apart from that it was fine!

Sorry to not be of much help. It was a good exercise to keep Barclays on their toes though.

Re: Barclays. Did the letter work? I'm about to do the same for my daughter. Any tips?

OK Process largely settled save for HL - "too big for their boots?"
Real $64K question? Prospects upside/downside? Thoughts?
- Must confess technology byond my area of competence.

Echo that with process, very easy via Charles Stanley.
Trellus applcation easy enough with AJBell - just a secure message to subscribe. HL holders disadvantaged - seems HL could not be bothered.
MHC RNS already posted above.
Having waded through much of the 23 pages of legalistic financial jargon I came to the conclusion this wasn't for me. There are apparent contradictions, e.g where it says " will need to..." and in the next paragraph "... if applicable..." - well is it needed always or only in some cases?
Also, the application can only be accepted by email but various copies must be "real ink originals or certified copies". I gave up.

Primary Bid did it much more easily a year ago (do they still?), including delivery to my nominee, which seemed to surprise my nominee!

Incidentally, I learned recently that HL were not currently accepting certifcates to transfer to nominee status but hoped to resume in due course..

I'd be interested in any response you get from HL. I may just wait until 28th and buy on the open market.
So, after a huge amount of effort, I have now applied for Trellus shares online, transferred funds and posted money laundering clearance details to LINK.

To say that the process was clunky/difficult would be a huge understatement. I used to do this sort of thing for a living and I still struggled to wade through the process. It took a lot of time and was all very much a last minute exercise. Not acceptable.

I suspect that most PI shareholders would have given up early on. I am going to give very specific feedback to Trellus/EKF, because I think that they need to sort out a much better process if they want to encourage PI involvement, which I believe that they do. The current process deters PIs from participating and that has to change. Obviously, I still have no idea as to whether I will be allotted shares/ get scaled back. I also had to apply direct, as I gave up waiting for Charles Stanley Direct to work out a procedure. Pretty pathetic, in my view.

Being honest, I don’t like the fact this large customer cannot be named. It’s all speculation as to who it can be even if it seems obvious. I’d like the relationship confirmed in writing for me to invest more than I have. Even after this latest update, share price change is modest over last few months and I’m thinking I can put my money to use in a better place.

Correct me if wrong but the end of year statement suggested to me that their old core business was flagging in comparison to their new products and yet in the AGM yesterday they advised they weren’t a COVID play.

Plus the antibody tests were a non starter, I thought there would be insane demand personally

I have an account with HL - anybody know whether it is possible to apply using HL's Crest details - so that shares get issued to your account with HL?

Alternatively is it easier to receive a share cert and forward it to HL and ask them to transfer shares to HL account?

I will call HL tomorrow (currently closed).

Lots of admin involved with any application!

Chat Pages: Latest  145  144  143  142  141  140  139  138  137  136  135  134  Older
Your Recent History
Ekf Diagno..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to ADVFN
Register Now

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20221208 10:24:02